Alvogen Licenses Mithra Contraceptive In Asia

Also Licensed Parkinson’s Disease Brands From Orion

Alvogen is expanding its presence in Asia by licensing a novel oral contraceptive from Belgium’s Mithra and striking a deal to market Orion’s Parkinson’s disease drugs.

Hong_Kong_Taiwan
Alvogen has licensed Mithra's novel Estelle oral contraceptive in Hong Kong and Taiwan • Source: Shutterstock

More from Deals

More from Business